Trust Co. of Vermont Makes New $8.42 Million Investment in Corteva, Inc. $CTVA

Trust Co. of Vermont bought a new stake in Corteva, Inc. (NYSE:CTVA) in the second quarter, HoldingsChannel reports. The fund bought 99,381 shares of the company’s stock, valued at approximately $8,417,000.

Other large investors also recently modified their holdings of the company. Harris Associates L P lifted its holdings in shares of Corteva by 168.1% during the 4th quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock valued at $1,141,268,000 after purchasing an additional 10,675,052 shares in the last quarter. Norges Bank bought a new stake in Corteva during the 4th quarter worth approximately $504,001,000. Royal Bank of Canada increased its stake in Corteva by 202.1% during the 1st quarter. Royal Bank of Canada now owns 7,458,624 shares of the company’s stock worth $624,362,000 after purchasing an additional 4,989,371 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in Corteva during the 2nd quarter worth approximately $392,447,000. Finally, Northwestern Mutual Wealth Management Co. raised its holdings in Corteva by 6,527.4% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,148,212 shares of the company’s stock worth $211,025,000 after buying an additional 3,100,709 shares during the period. 81.54% of the stock is currently owned by institutional investors.

Corteva Trading Down 1.2%

NYSE:CTVA opened at $75.73 on Tuesday. The company has a market cap of $50.53 billion, a P/E ratio of 50.15, a price-to-earnings-growth ratio of 2.35 and a beta of 0.57. Corteva, Inc. has a twelve month low of $60.53 and a twelve month high of $90.97. The business has a 50 day moving average price of $81.78 and a two-hundred day moving average price of $80.09. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.24 by $0.06. The company had revenue of $6.38 billion for the quarter, compared to the consensus estimate of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The firm’s revenue was down 1.2% compared to the same quarter last year. During the same period last year, the company earned $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, analysts expect that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be paid a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 1.0%. The ex-dividend date is Tuesday, September 1st. Corteva’s payout ratio is presently 47.68%.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on CTVA shares. Bank of America upped their price target on shares of Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a report on Monday, July 20th. Jefferies Financial Group raised their price objective on shares of Corteva from $95.00 to $97.00 in a report on Thursday, May 7th. Mizuho boosted their price objective on shares of Corteva from $96.00 to $97.00 and gave the company an “outperform” rating in a research report on Tuesday, July 14th. Weiss Ratings lowered shares of Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, August 3rd. Finally, Rothschild & Co Redburn increased their target price on Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Wednesday, April 29th. Fourteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $91.70.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.